cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.7226845
title: Energy of shallow tremors and moment of shallow very low frequency earthquakes in Hyuga-nada, southwest Japan

description: We estimated energies of shallow tremors detected by Yamashita et al. (2015) and Yamashita et al. (2021), and moments of shallow very low frequency earthquakes (VLFEs) detected by Asano et al. (2015) and those temporally correlated with shallow tremors detected by Yamashita et al. (2015) and Yamashita et al. (2021) in Hyuga-nada. We also evaluated scaled energies of shallow slow earthquakes in Hyuga-nada by the ratio of energy rate of tremors to moment rate of accompanying VLFEs. The method of estimation of energies of tremors and moments of VLFEs is written in a submitted paper. The content of each column is written in the first line of each file. tremor_2013.txt: Energy of shallow tremors in 2013 detected by Yamashita et al. (2015) (https://doi.org/10.1126/science.aaa4242).<br> tremor_2015.txt: Energy of shallow tremors in 2015 detected by Yamashita et al. (2021) (https://doi.org/10.1186/s40623-021-01533-x).<br> VLFE_2010.txt: Moments of shallow VLFEs in 2010 detected by Asano et al. (2015) (https://doi.org/10.1002/2014GL062165).<br> VLFE_2013.txt: Moments of shallow VLFEs correlated with shallow tremors in 2013 detected by Yamashita et al. (2015) (https://doi.org/10.1126/science.aaa4242) and scaled energy of slow earthquakes.<br> VLFE_2015.txt: Moments of shallow VLFEs correlated with shallow tremors in 2015 detected by Yamashita et al. (2021) (https://doi.org/10.1186/s40623-021-01533-x) and scaled energy of slow earthquakes.<br>
DOI: 10.5281/zenodo.8220097
title: Energy of shallow tremors and moment of shallow very low frequency earthquakes in Hyuga-nada, southwest Japan

description: We estimated energies of shallow tremors detected by Yamashita et al. (2015) and Yamashita et al. (2021), and moments of shallow very low frequency earthquakes (VLFEs) detected by Asano et al. (2015) and those temporally correlated with shallow tremors detected by Yamashita et al. (2015) and Yamashita et al. (2021) in Hyuga-nada. We also evaluated scaled energies of shallow slow earthquakes in Hyuga-nada by the ratio of energy rate of tremors to moment rate of accompanying VLFEs.

The method of estimation of energies of tremors and moments of VLFEs is written in Baba et al. (2024  https://doi.org/10.1093/gji/ggae039). The content of each column is written in the first line of each file. The time is written in JST (UTC+9).

tremor_2013.txt: Energy of shallow tremors in 2013 detected by Yamashita et al. (2015) (https://doi.org/10.1126/science.aaa4242).tremor_2015.txt: Energy of shallow tremors in 2015 detected by Yamashita et al. (2021) (https://doi.org/10.1186/s40623-021-01533-x).VLFE_2010.txt: Moments of shallow VLFEs in 2010 detected by Asano et al. (2015) (https://doi.org/10.1002/2014GL062165).VLFE_2013.txt: Moments of shallow VLFEs correlated with shallow tremors in 2013 detected by Yamashita et al. (2015) (https://doi.org/10.1126/science.aaa4242) and scaled energy of slow earthquakes.VLFE_2015.txt: Moments of shallow VLFEs correlated with shallow tremors in 2015 detected by Yamashita et al. (2021) (https://doi.org/10.1186/s40623-021-01533-x) and scaled energy of slow earthquakes.(Version 2: site amplification factors of tremor energy estimation at the reference station N.TASF was changed to be set as 2)
DOI: 10.25582/data.2021-09.2318586/2286228
title: Data for EMSL Project 51834 from September 2021
DOI: 10.6084/m9.figshare.20495919
title: Additional file 5 of Genome-wide association study identifying genetic variants associated with carcass backfat thickness, lean percentage and fat percentage in a four-way crossbred pig population using SLAF-seq technology

description: Additional file 5: Table S3. Comparison of significant SNPs with previously reported QTLs from the pig QTL database and newly significant SNPs for fatness-related traits.
DOI: 10.25582/data.2022-09.2608751/2286229
title: Data for EMSL Project 51834 from September 2022
DOI: 10.6084/m9.figshare.20495919.v1
title: Additional file 5 of Genome-wide association study identifying genetic variants associated with carcass backfat thickness, lean percentage and fat percentage in a four-way crossbred pig population using SLAF-seq technology

description: Additional file 5: Table S3. Comparison of significant SNPs with previously reported QTLs from the pig QTL database and newly significant SNPs for fatness-related traits.
DOI: 10.6084/m9.figshare.6866285.v1
title: ABO blood type and risk of hepatocellular carcinoma: a meta-analysis

description: <b>Background</b>: ABO blood type is an invariant factor. There is a link between ABO blood type and some malignancies, such as gastric, pancreatic, and skin cancer. The role of ABO blood type in the pathogenesis of hepatocellular carcinoma (HCC) remains controversial. We performed a meta-analysis to explore the relationship between ABO blood type and risk of HCC. <b>Methods</b>: Literature search was conducted among the PubMed, EMBASE, and Cochrane Library databases. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. <b>Results</b>: Seven papers were included. They included 92,847 healthy subjects, 5,463 patients with hepatitis, 294 cirrhotic patients, and 3,322 HCC patients. The proportion of blood type O was significantly lower in HCC patients than healthy subjects (OR = 0.76, 95%CI = 0.66–0.87, P &lt; 0.0001) without any significant heterogeneity (P = 0.55, I<sup>2</sup> = 0%). The proportions of blood types A, B, and <i>AB</i> were not significantly different between HCC patients and healthy subjects. The proportion of ABO blood type was not significantly different between patients with HCC and those with hepatitis or cirrhosis. <b>Conclusion</b>: HCC patients might have a lower proportion of blood type O than healthy subjects. Among the patients with chronic liver diseases, ABO blood type might not be associated with the risk of HCC.
DOI: 10.6084/m9.figshare.6866285
title: ABO blood type and risk of hepatocellular carcinoma: a meta-analysis

description: <b>Background</b>: ABO blood type is an invariant factor. There is a link between ABO blood type and some malignancies, such as gastric, pancreatic, and skin cancer. The role of ABO blood type in the pathogenesis of hepatocellular carcinoma (HCC) remains controversial. We performed a meta-analysis to explore the relationship between ABO blood type and risk of HCC. <b>Methods</b>: Literature search was conducted among the PubMed, EMBASE, and Cochrane Library databases. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. <b>Results</b>: Seven papers were included. They included 92,847 healthy subjects, 5,463 patients with hepatitis, 294 cirrhotic patients, and 3,322 HCC patients. The proportion of blood type O was significantly lower in HCC patients than healthy subjects (OR = 0.76, 95%CI = 0.66–0.87, P &lt; 0.0001) without any significant heterogeneity (P = 0.55, I<sup>2</sup> = 0%). The proportions of blood types A, B, and <i>AB</i> were not significantly different between HCC patients and healthy subjects. The proportion of ABO blood type was not significantly different between patients with HCC and those with hepatitis or cirrhosis. <b>Conclusion</b>: HCC patients might have a lower proportion of blood type O than healthy subjects. Among the patients with chronic liver diseases, ABO blood type might not be associated with the risk of HCC.
DOI: 10.6084/m9.figshare.7390769.v1
title: Protective effects of Polygonatum sibiricum polysaccharide on acute heart failure in rats

description: Abstract Purpose: To investigate the protective effects of Polygonatum sibiricum polysaccharide (PSP) on acute heart failure (AHF) in rats. Methods: Sixty rats were randomly divided into control, model, and low-, middle- and high-dose PSP groups, 12 rats in each group. The low-, medium- and high-dose PSP groups were intragastrically administrated with 100, 200 and 400 mg/kg PSP for 5 days, respectively. On the sixth day, the AHF model was established by intraperitoneal injection of adriamycin. After 24h, the cardiac function, serum biochemical indexes, myocardial ATPase and succinate dehydrogenase levels and apoptosis related protein expressions were determined. Results: Compared with model group, in high-dose PSP group the heart rate, left ventricular systolic pressure, ±dp/dtmax, serum superoxide dismutase level, myocardial Na+-K+-ATPase, Ca2+-Mg2+-ATPase and succinate dehydrogenase levels and myocardial Bcl-2 and Caspase-3 protein expression levels were significantly increased (P&lt;0.05), the left ventricular end diastolic pressure, serum cTnI, CK-MB, TNF-α, IL-6, malondialdehyde and nitric oxide levels and myocardial Bax and cleaved Caspase-3 protein expression levels were significantly decreased (P&lt;0.05). Conclusions: Polysaccharide can prevent the acute heart failure induced by adriamycin. The mechanism may be related to its anti-oxidative stress, anti-inflammation and inhibition of cardiac myocyte apoptosis.
DOI: 10.25582/data.2021-10.2363654/2286230
title: Data for EMSL Project 51834 from October 2021
DOI: 10.6084/m9.figshare.7390772.v1
title: Analysis of the application values of different combination schemes of liquid-based cytology and high-risk human papilloma virus test in the screening of high-grade cervical lesions

description: The aim of this study was to explore the value of different combination schemes of liquid-based cytology (LBC) and high-risk human papilloma virus (HPV) test in the screening of high-grade (≥CIN 2) cervical lesions. From 5727 women who had undergone examinations with LBC and high-risk HPV test, 1884 patients with positive results of either or both LBC and HPV test were included in this study and underwent cervical biopsy. Based on the pathological examination results, comparisons of the assessment indicators of all diagnostic tests were made, and the application values of LBC and high-risk HPV test and different combination schemes of the two in the screening of high-grade (≥CIN II) cervical lesions were estimated. Compared with the single test method, the sensitivity and negative predictive value of the combination scheme of LBC+HPV (with one positive result) were increased significantly (98.7% and 99.7%), but the specificity (60.8%) and accuracy rate (65.4%) dropped significantly (P&lt;0.05). The sensitivity of LBC+HPV (with two positive results) was the lowest (80.7%), but the specificity and accuracy rate were the highest (83.5% and 83.1%, P&lt;0.05). Z test showed that differences in the screening efficiency of four schemes were not statistically significant (P&gt;0.05). Both LBC and HPV test were effective methods in the screening of high-grade cervical lesions; combination of the two tests did not improve the screening efficiency, but the scheme of LBC+HPV (with two positive results) significantly increased the sensitivity and negative predictive value, which was of better cost-benefit value.
DOI: 10.6084/m9.figshare.20495860.v1
title: Additional file 1 of Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

description: Additional file 1: Table S1. Genes tested on GERMLINE MSK-IMPACT test.
DOI: 10.6084/m9.figshare.7915175
title: Additional file 1: of RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3

description: Table S1. Primer lists used in this study. (XLSX 10 kb)
DOI: 10.25582/data.2022-10.2620113/2286231
title: Data for EMSL Project 51834 from October 2022
DOI: 10.6084/m9.figshare.7915190
title: Additional file 3: of Reprogramming histone modification patterns to coordinate gene expression in early zebrafish embryos

description: Table S2. Pairwise dissimilarities for each stage in mouse (XLSX 9 kb)
DOI: 10.25582/data.2021-08.2305217/2286232
title: Data for EMSL Project 51834 from August 2021
DOI: 10.6084/m9.figshare.7390787
title: Necroptosis occurs in osteoblasts during tumor necrosis factor-α stimulation and caspase-8 inhibition

description: Necroptosis is a regulated cell death mechanism. However, it is unknown whether necroptosis is involved in the death of tumor necrosis factor-α (TNF-α)-treated osteoblasts. Therefore, we conducted the study with TNF-α, Nec-1 (a specific inhibitor of necroptosis), and Z-IETD-FMK (a specific inhibitor of apoptosis) to determine whether necroptosis plays a role in the death of TNF-α-treated osteoblast cell line MC3T3-E1. Cell viability, cell death, and lactate dehydrogenase (LDH) release were assayed to evaluate cytotoxicity. Specific marker proteins receptor interacting protein kinase (RIPK3) and phosphorylated mixed lineage kinase domain-like protein (p-MLKL) for necroptosis, and cleaved caspase 3 for apoptosis were detected by western blot, and mRNA was measured by quantitative real-time polymerase chain reaction (qRT-PCR). We found that TNF-α inhibited cell proliferation in a dose- and time-dependent manner. Nec-1 plus Z-IETD-FMK restored cell viability and significantly decreased LDH release. In addition, TNF-α alone increased the cell population of AV+PI−, while Z-IETD-FMK caused a shift in the cell population from AV+PI− to AV+PI+. Furthermore, TNF-α significantly increased protein cleaved caspase 3. TNF-α plus Z-IETD-FMK significantly increased the proteins RIPK3 and MLKL phosphorylation in MC3T3-E1 cells, while the changes in mRNA levels of RIPK3, MLKL, and caspase 3 were not consistent with the changes in the corresponding protein expression levels. In conclusion, TNF-α induced preferentially apoptosis in osteoblast cell line and necroptosis played a decisive role when TNF-α-induced death was inhibited by the inhibitor of apoptosis. Combined treatment with Nec-1 and Z-IETD-FMK protected mouse osteoblasts from death induced by TNF-α.
DOI: 10.6084/m9.figshare.7915190.v1
title: Additional file 3: of Reprogramming histone modification patterns to coordinate gene expression in early zebrafish embryos

description: Table S2. Pairwise dissimilarities for each stage in mouse (XLSX 9 kb)
DOI: 10.6084/m9.figshare.7390634.v1
title: Analysis of BMSCs-intervened viscoelasticity of sciatic nerve in rats with chronic alcoholic intoxication

description: Abstract Purpose: To investigate the impact of bone mesenchymal stem cells (BMSCs) intervention on the viscoelasticity of sciatic nerve in rats with chronic alcohol intoxication (CAI). Methods: The CAI rat models were prepared, divided into model groups, and treated with either BMSCs or basic fibroblast growth factor (bFGF). Then the rats underwent electrophysiological test and the serum levels of malondialdehyde (MDA), superoxide dismutase (SOD), and metallothionein (MT) were measured. Histological observation, stress relaxation test, and creep test were performed for the sciatic nerve of the CAI model in each group. Results: The MDA level of group BMSC was significantly lower (p&lt;0.05) than that of groups MOD (the CIA model) and bFGF. The SOD and MT levels were higher in group BMSC than in groups MOD and bFGF (p&lt;0.05). The motor nerve conduction velocity and amplitude were higher in group BMSC than in groups MOD and bFGF (p&lt;0.05). The amounts of 7200s stress reduction and 7200 s strain increase of the sciatic nerve in group BMSC were greater than those in groups bFGF and MOD (p&lt;0.05). Conclusion: Bone mesenchymal stem cells can improve the metabolism of free radicals, restore the tissue morphology and viscoelasticity of the chronic alcohol intoxication animal model, and positively affect the repairing of the injured sciatic nerve.
DOI: 10.25582/data.2021-11.2380534/2286233
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2021-11.2389054/2286234
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2022-01.2417267/2286235
title: Data for EMSL Project 51834 from January 2022
DOI: 10.25582/data.2022-01.2417588/2286236
title: Data for EMSL Project 51834 from January 2022
DOI: 10.25582/data.2022-09.2609806/2286237
title: Data for EMSL Project 51834 from September 2022
DOI: 10.25582/data.2021-11.2387530/2286238
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2021-09.2318476/2286239
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2021-11.2380557/2286240
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2022-09.2606808/2286241
title: Data for EMSL Project 51834 from September 2022
DOI: 10.25582/data.2022-10.2621884/2286242
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2022-10.2620156/2286243
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-11.2387280/2286244
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2022-10.2621076/2286245
title: Data for EMSL Project 51834 from October 2022
DOI: 10.6084/m9.figshare.7392089
title: Additional file 29: of The chicken gut metagenome and the modulatory effects of plant-derived benzylisoquinoline alkaloids

description: Table S8. The relative mRNA levels of cytokines in the ileum of Arbor Acres broiler chickens on days 21 and 42. (XLSX 11 kb)
DOI: 10.6084/m9.figshare.7392089.v1
title: Additional file 29: of The chicken gut metagenome and the modulatory effects of plant-derived benzylisoquinoline alkaloids

description: Table S8. The relative mRNA levels of cytokines in the ileum of Arbor Acres broiler chickens on days 21 and 42. (XLSX 11 kb)
DOI: 10.25582/data.2021-11.2388556/2286246
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2022-10.2621545/2286247
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-10.2352008/2286248
title: Data for EMSL Project 51834 from October 2021
DOI: 10.6084/m9.figshare.7392095.v1
title: Additional file 30: of The chicken gut metagenome and the modulatory effects of plant-derived benzylisoquinoline alkaloids

description: Table S9. Primers used for quantitative real-time PCR. (XLSX 28 kb)
DOI: 10.25582/data.2022-01.2416953/2286249
title: Data for EMSL Project 51834 from January 2022
DOI: 10.25582/data.2022-04.2479172/2286250
title: Data for EMSL Project 51834 from April 2022
DOI: 10.25582/data.2021-11.2380347/2286251
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2022-09.2607850/2286252
title: Data for EMSL Project 51834 from September 2022
DOI: 10.25582/data.2022-09.2609330/2286253
title: Data for EMSL Project 51834 from September 2022
DOI: 10.25582/data.2022-10.2615002/2286254
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-10.2372848/2286255
title: Data for EMSL Project 51834 from October 2021
DOI: 10.25582/data.2022-10.2620544/2286256
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-09.2329992/2286257
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2022-04.2479166/2286258
title: Data for EMSL Project 51834 from April 2022
DOI: 10.25582/data.2021-12.2410948/2286259
title: Data for EMSL Project 51834 from December 2021
DOI: 10.25582/data.2022-04.2478410/2286260
title: Data for EMSL Project 51834 from April 2022
DOI: 10.25582/data.2021-09.2321504/2286261
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2021-12.2411226/2286262
title: Data for EMSL Project 51834 from December 2021
DOI: 10.25582/data.2022-04.2478893/2286263
title: Data for EMSL Project 51834 from April 2022
DOI: 10.25582/data.2022-10.2614907/2286264
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-10.2361813/2286265
title: Data for EMSL Project 51834 from October 2021
DOI: 10.25582/data.2021-10.2361588/2286266
title: Data for EMSL Project 51834 from October 2021
DOI: 10.25582/data.2021-12.2389907/2286267
title: Data for EMSL Project 51834 from December 2021
DOI: 10.25582/data.2022-09.2608821/2286268
title: Data for EMSL Project 51834 from September 2022
DOI: 10.25582/data.2022-10.2614435/2286269
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2022-10.2622377/2286270
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-09.2329621/2286271
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2021-08.2303242/2286272
title: Data for EMSL Project 51834 from August 2021
DOI: 10.25582/data.2022-01.2417519/2286273
title: Data for EMSL Project 51834 from January 2022
DOI: 10.25582/data.2021-11.2385121/2286274
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2021-09.2319789/2286275
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2021-11.2387649/2286276
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2021-08.2305331/2286277
title: Data for EMSL Project 51834 from August 2021
DOI: 10.25582/data.2021-09.2314519/2286278
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2021-10.2353319/2286279
title: Data for EMSL Project 51834 from October 2021
DOI: 10.25582/data.2021-11.2387025/2286280
title: Data for EMSL Project 51834 from November 2021
DOI: 10.25582/data.2021-09.2326394/2286281
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2021-09.2318866/2286282
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2021-12.2400028/2286283
title: Data for EMSL Project 51834 from December 2021
DOI: 10.6084/m9.figshare.23118983
title: Additional file 2 of New insight into the genetic basis of oil content based on noninvasive three-dimensional phenotyping and tissue-specific transcriptome in Brassica napus

description: Additional file 2: Table S1. Mean values and phenotypic variation for oil content in different tissues of seeds in the KN DH population. Table S2. Pearson correlation coefficients for trait pairs affecting the oil content of seeds in the KN DH population. Table S3. The allele type of each DH line in 12 accessed TO-QTLs. Table S4. Characteristics of sequencing data for RAN-Seq.
DOI: 10.25582/data.2021-12.2411324/2286284
title: Data for EMSL Project 51834 from December 2021
DOI: 10.25582/data.2021-12.2389774/2286285
title: Data for EMSL Project 51834 from December 2021
DOI: 10.25582/data.2022-04.2479168/2286286
title: Data for EMSL Project 51834 from April 2022
DOI: 10.25582/data.2022-09.2612283/2286287
title: Data for EMSL Project 51834 from September 2022
DOI: 10.25582/data.2022-01.2417405/2286288
title: Data for EMSL Project 51834 from January 2022
DOI: 10.25582/data.2022-09.2607784/2286289
title: Data for EMSL Project 51834 from September 2022
DOI: 10.25582/data.2022-10.2613942/2286290
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2022-10.2614709/2286291
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-12.2399671/2286292
title: Data for EMSL Project 51834 from December 2021
DOI: 10.58024/agum_tog2024
title: Global Kimberlite Database - Treatise on Geochemistry
DOI: 10.25582/data.2022-10.2617107/2286293
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-12.2399776/2286294
title: Data for EMSL Project 51834 from December 2021
DOI: 10.25582/data.2022-10.2620718/2286295
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2021-09.2322472/2286296
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2021-09.2322612/2286297
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2022-10.2617765/2286298
title: Data for EMSL Project 51834 from October 2022
DOI: 10.6084/m9.figshare.7915214.v1
title: Additional file 7: of Reprogramming histone modification patterns to coordinate gene expression in early zebrafish embryos

description: Table S6. Enriched GO and INTERPRO domains for active gene group in mouse. (XLSX 15 kb)
DOI: 10.25582/data.2022-10.2621303/2286299
title: Data for EMSL Project 51834 from October 2022
DOI: 10.25582/data.2022-09.2608783/2286300
title: Data for EMSL Project 51834 from September 2022
DOI: 10.25582/data.2021-09.2327582/2286301
title: Data for EMSL Project 51834 from September 2021
DOI: 10.25582/data.2022-09.2609307/2286302
title: Data for EMSL Project 51834 from September 2022